Skip to main content

Table 1 Sociodemographic and anthropometric characteristics and maternal background of 959 low-medium income pre-schoolers from the Food and Environment Chilean Cohort (FECHIC)

From: Consumption of non-nutritive sweeteners by pre-schoolers of the food and environment Chilean cohort (FECHIC) before the implementation of the Chilean food labelling and advertising law

 

Total Sample

Female [n (%)]

498 (51.9)

Age, y [median (IQR)]

4.7 (4.4–5.0)

Age of the child’s mother, y [median (IQR)]

31 (26–36)

Level of maternal education [n (%)]

 Low (<  12 years of study)

171 (17.8)

 Medium (12 years of study)

397 (41.4)

 High (>  12 years of study)

391 (40.8)

Child’s mother works out of home [n (%)]

478 (49.8)

Weight, kg [median (IQR)]

19.2 (17.4–21.6)

Height, cm [median (IQR)]

107.4 (104.2–111.2)

Weight status [n (%)] a

 Normal weight (−2SD < BMI-for age z-score < +1SD)

508 (53.0)

 Overweight (+1SD < BMI-for-age z-score < +2SD)

276 (28.8)

 Obese (BMI-for-age z-score > +2SD)

175 (18.2)

Waist circumference, cm [median (IQR)] b

54.4 (51.5–57.8)

Children’s abdominal obesity [n (%)] bc

92 (9.6)

Maternal weight status [n (%)] de

 Underweight (BMI <18.5 kg/m2)

6 (0.6)

 Normal (BMI 18.5–24.9 kg/m2)

237 (25.8)

 Overweight (BMI 25–29.9 kg/m2)

350 (38.1)

 Obese (BMI > 30 kg/m2)

326 (35.5)

Maternal abdominal obesity [n (%)] ef

509 (55.4)

  1. aDefined based on WHO Child Growth Standards 2006 for children under 5-years-old and WHO Growth Reference 2007 for children above 5 years-old [46, 47, 53]
  2. bData were available for 957 preschool children, two children refused to be measured
  3. cWaist circumference measures were compared to USA percentiles describe by Fernandez et al. [49] and Cook et al. criteria was used to assess abdominal obesity among children [50]
  4. dDefined based on WHO cut-off points for Body Mass Index in adults [48]
  5. eData were available for 919 mothers; 38 mothers were pregnant and two refused to be measured
  6. fDefined based on the criteria for clinical identification of metabolic syndrome described by the Adult Treatment Panel III 2001 [51]